BeStock  
Stocks › Biotechnology › SANA

Sana Biotechnology SANA

US equityMarket cap rank #3398Biotechnology
$2.70 −$0.02 (-0.74%)
Market open · Oct 8, 10:00 am ET · After hours $2.80 +2.94%
Open$2.72
Prev close$2.72
Day range$2.66 – $2.73
Volume345.5K
Market cap$808.27M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$65.42M-29.9% YoY
Net profit-$63.64M+32.2% YoY
Diluted EPS-$0.22+43.6% YoY
Free cash flow-$34.41M-4.3% YoY
Operating cash flow-$32.79M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-59.9MSep '24$-49.1MDec '24$-49.4MMar '25$-93.8MJun '25$-42.2MSep '25$-58.8MDec '25$-47.2MMar '26$-63.6MJun '26

Diluted EPS by quarter

-0.25Sep '24-0.21Dec '24-0.21Mar '25-0.39Jun '25-0.16Sep '25-0.21Dec '25-0.17Mar '26-0.22Jun '26

Free cash flow by quarter

$-55.9MSep '24$-47.6MDec '24$-48.8MMar '25$-33.0MJun '25$-29.5MSep '25$-33.5MDec '25$-37.7MMar '26$-34.4MJun '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-152.9%
Return on assets-53.4%
Return on invested capital-99.1%
Current ratio1.38
Liabilities / assets64.2%
Cash & investments$160.49M
Total debt$59.23M
Net cash (debt)$101.26M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $65.42M $48.61M $205.71M $61.20M $43.52M
Selling and Admin Expenses $10.78M $11.46M $44.30M $12.19M $10.29M
-General & Admin Expense $10.78M $11.46M $44.30M $12.19M $10.29M
Research & Development $54.64M $37.15M $161.41M $49.01M $33.23M
Operating Profit -$65.42M -$48.61M -$205.71M -$61.20M -$43.52M
Net Non-Operating Interest Income (Expense) $1.13M $951,000.00 $3.85M $1.28M $1.00M
Non-Operating Interest Income $1.13M $951,000.00 $3.85M $1.28M $1.00M
Other Income (Expense) $656,000.00 $453,000.00 -$42.31M $1.10M $360,000.00
Special Income (Charges) $0.00 – -$44.61M $0.00 $0.00
-Less:Impairment of Capital Assets $0.00 – $44.61M $0.00 $0.00
Other Non-Operating Income (Expenses) $656,000.00 $453,000.00 $2.31M $1.10M $360,000.00
Pretax Profit -$63.64M -$47.21M -$244.17M -$58.83M -$42.15M
Net Profit -$63.64M -$47.21M -$244.17M -$58.83M -$42.15M
Profit from Continuing Operations -$63.64M -$47.21M -$244.17M -$58.83M -$42.15M
Net Income to Parent Company -$63.64M -$47.21M -$244.17M -$58.83M -$42.15M
Net Income to Common Stockholders -$63.64M -$47.21M -$244.17M -$58.83M -$42.15M
Basic EPS -$0.22 -$0.17 -$0.96 -$0.21 -$0.16
Diluted EPS -$0.22 -$0.17 -$0.96 -$0.21 -$0.16

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $431.52M $373.59M $416.89M $416.89M $435.43M
Total Current Assets $170.63M $111.69M $148.68M $148.68M $161.76M
Cash and Cash Equivalents & Short-Term Investments $160.49M $101.14M $138.38M $138.38M $153.05M
-Cash and Cash Equivalents $57.07M $83.80M $71.87M $71.87M $103.36M
-Short Term Investments $103.42M $17.34M $66.51M $66.51M $49.70M
Restricted Cash $4.20M $4.20M $4.20M $4.20M $4.20M
Other Current Assets $5.94M $6.36M $6.10M $6.10M $4.51M
Total Non-Current Assets $260.89M $261.90M $268.21M $268.21M $273.67M
Net PPE $60.52M $61.52M $65.22M $65.22M $70.64M
-Gross PPE $119.90M $118.66M $119.97M $119.97M $124.48M
-Accumulated Depreciation -$59.38M -$57.15M -$54.76M -$54.76M -$53.84M
Goodwill and Other Intangible Assets $199.82M $199.82M $199.82M $199.82M $199.82M
-Goodwill $140.63M $140.63M $140.63M $140.63M $140.63M
-Other Intangible Assets $59.20M $59.20M $59.20M $59.20M $59.20M
Other Non-Current Assets $552,000.00 $563,000.00 $3.17M $3.17M $3.22M
Total Liabilities $276.95M $254.35M $256.01M $256.01M $240.12M
Total Current Liabilities $123.75M $86.27M $78.73M $78.73M $35.51M
Payables $1.36M $2.12M $1.67M $1.67M $1.86M
-Accounts Payable $1.36M $2.12M $1.67M $1.67M $1.86M
Current Accrued Expenses $9.67M $10.32M $10.19M $10.19M $9.99M
Short-Term Debt and Capital Lease Obligation $14.51M $14.88M $14.94M $14.94M $14.37M
-Current Capital Lease Obligation $14.51M $14.88M $14.94M $14.94M $14.37M
Other Current Liabilities $90.81M $53.56M $40.20M $40.20M –
Total Non-Current Liabilities $153.20M $168.09M $177.28M $177.28M $204.61M
Long Term Debt and Capital Lease Obligation $59.23M $60.45M $63.92M $63.92M $67.87M
-Long Term Capital Lease Obligation $59.23M $60.45M $63.92M $63.92M $67.87M
Other Non-Current Liabilities $93.97M $107.64M $113.36M $113.36M $136.74M
Total Equity $154.57M $119.24M $160.88M $160.88M $195.31M
Stockholders' Equity $154.57M $119.24M $160.88M $160.88M $195.31M
Capital Stock $30,000.00 $27,000.00 $27,000.00 $27,000.00 $26,000.00
-Common Stock $30,000.00 $27,000.00 $27,000.00 $27,000.00 $26,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.11B $2.02B $2.01B $2.01B $1.99B
Retained Earnings -$1.96B -$1.90B -$1.85B -$1.85B -$1.79B
Gains/Losses Not Affecting Retained Earnings -$66,000.00 -$2,000.00 $28,000.00 $28,000.00 $21,000.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$32.79M -$37.38M -$143.83M -$32.64M -$29.43M
Net cash flow from continuing operations -$32.79M -$37.38M -$143.83M -$32.64M -$29.43M
Net Income from Continuing Operations -$63.64M -$47.21M -$244.17M -$58.83M -$42.15M
Depreciation & Depletion & Amortization $2.23M $2.39M $12.75M $3.05M $3.19M
Other Non-Cash Items $22.15M $8.29M $27.63M $13.38M $3.36M
Change in Working Capital $1.12M -$6.51M -$10.11M $3.41M $697,000.00
-Change in Prepaid Assets $295,000.00 $1.63M $1.17M -$696,000.00 $1.12M
-Change in Payables and Accrued Expense $271,000.00 -$6.64M -$8.28M $5.57M $1.03M
-Change In Other Working Capital $556,000.00 -$1.50M -$3.00M -$1.46M -$1.46M
Net cash flow from investing -$87.52M $49.44M -$40.24M -$16.50M -$48.03M
Net Cash Flow from Continuing Investing Activities -$87.52M $49.44M -$40.24M -$16.50M -$48.03M
Net PPE Purchase and Sale -$1.62M -$288,000.00 -$938,000.00 -$873,000.00 -$41,000.00
Net Investment Purchase and Sale -$85.92M $49.48M -$40.73M -$16.28M -$48.12M
Net Other Investing Changes $23,000.00 $248,000.00 $1.43M $661,000.00 $136,000.00
Financing Cash Flow $93.58M -$128,000.00 $128.73M $17.65M $109.54M
Net Cash Flow from Continuing Financing Activities $93.58M -$128,000.00 $128.73M $17.65M $109.54M
Proceeds from Stock Option Exercised $245,000.00 $59,000.00 $2.68M $1.06M $157,000.00
Net Other Financing Charges -$88,000.00 -$96,000.00 – – -$87,000.00
Ending Cash Balance $61.27M $88.00M $76.07M $76.07M $107.55M
Net Change in Cash -$26.73M $11.93M -$55.33M -$31.49M $32.09M
Beginning Cash Balance $88.00M $76.07M $131.40M $107.55M $75.47M
Free Cash Flow -$34.41M -$37.67M -$144.77M -$33.51M -$29.47M
Net Issuance Payments Of Debt – -$91,000.00 $126.06M – –
Net Common Stock Issuance – – – – $109.47M

Discussion

No comments yet — be the first to weigh in on SANA.

Leave a comment

Scroll to Top